Do you have a question about the Lantus SoloSTAR and is the answer not in the manual?
Type | Disposable Insulin Pen |
---|---|
Insulin Type | Long-acting |
Brand Name | Lantus SoloSTAR |
Generic Name | Insulin Glargine |
Dosage Form | Solution for injection |
Concentration | 100 units/mL (U-100) |
Delivery Method | Subcutaneous injection |
Dosage Increments | 1 unit |
Maximum Dose | 80 units per injection |
Needle Compatibility | Compatible with most pen needles |
Pen Capacity | 3 mL |
Storage | Refrigerate unused pens; store in-use pens at room temperature |
Describes the intended uses of Lantus for diabetes management in adults and children.
Provides crucial safety warnings and precautions for using Lantus.
Details safety aspects specific to the Lantus SoloSTAR pre-filled insulin pen.
Details essential preparation steps like washing hands, checking insulin clarity, and warming the pen.
Provides step-by-step instructions on how to attach a new needle correctly to the pen.
Guides users through the process of performing a safety test to ensure proper pen and needle function.
Explains how to set the desired insulin dose using the pen's dose selector and related precautions.
Provides instructions on the proper technique for injecting insulin using the Lantus SoloSTAR pen.
Guides users on the correct procedure for safely removing and disposing of the needle after injection.
Details important safety warnings and precautions for using Lantus.
Details the risks and management of low blood sugar (hypoglycemia) with Lantus.
Reports on the incidence of severe hypoglycemia observed in Lantus clinical trials.
Offers essential instructions for patients on using Lantus safely and effectively.
Highlights critical information patients must know before using Lantus.
Provides detailed instructions on how to use Lantus and related devices.
Details the causes, symptoms, and management of hypoglycemia.
Explains the causes, symptoms, and risks associated with hyperglycemia.
Lists various symptoms of hypoglycemia, including subtle or absent warning signs.
Discusses hyperglycemia, its progression to DKA, and symptoms.